Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.76M
-
Shares change
-
+115K
-
Total reported value, excl. options
-
$6.58M
-
Value change
-
+$290K
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$3.74
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q2 2022
17 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q2 2022.
Journey Medical Corp - Common Stock (DERM) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.76M shares
of 17.2M outstanding shares and own 10.23% of the company stock.
Largest 10 shareholders include B. Riley Financial, Inc. (865K shares), Opaleye Management Inc. (246K shares), PERKINS CAPITAL MANAGEMENT INC (220K shares), Neuberger Berman Group LLC (197K shares), AMERICAN FINANCIAL GROUP INC (180K shares), B. Riley Wealth Management, Inc. (15K shares), Creative Planning (11.8K shares), VANGUARD GROUP INC (10.4K shares), BlackRock Inc. (8.49K shares), and UBS Group AG (2.69K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.